Frontiers in Neurology (Sep 2021)
Stability of MDS-UPDRS Motor Subtypes Over Three Years in Early Parkinson's Disease
- Abhijeet K. Kohat,
- Abhijeet K. Kohat,
- Samuel Y. E. Ng,
- Samuel Y. E. Ng,
- Aidan S. Y. Wong,
- Aidan S. Y. Wong,
- Nicole S. Y. Chia,
- Nicole S. Y. Chia,
- Xinyi Choi,
- Xinyi Choi,
- Dede L. Heng,
- Dede L. Heng,
- Wei Li,
- Wei Li,
- Hwee-Lan Ng,
- Hwee-Lan Ng,
- Shu-Ting Chua,
- Shu-Ting Chua,
- Shermyn X. M. Neo,
- Shermyn X. M. Neo,
- Zheyu Xu,
- Zheyu Xu,
- Kay-Yaw Tay,
- Kay-Yaw Tay,
- Kay-Yaw Tay,
- Wing-Lok Au,
- Wing-Lok Au,
- Wing-Lok Au,
- Eng-King Tan,
- Eng-King Tan,
- Eng-King Tan,
- Louis C. S. Tan,
- Louis C. S. Tan,
- Louis C. S. Tan
Affiliations
- Abhijeet K. Kohat
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Abhijeet K. Kohat
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Samuel Y. E. Ng
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Samuel Y. E. Ng
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Aidan S. Y. Wong
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Aidan S. Y. Wong
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Nicole S. Y. Chia
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Nicole S. Y. Chia
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Xinyi Choi
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Xinyi Choi
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Dede L. Heng
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Dede L. Heng
- Duke-NUS Graduate Medical School, Singapore, Singapore
- Wei Li
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Wei Li
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Hwee-Lan Ng
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Hwee-Lan Ng
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Shu-Ting Chua
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Shu-Ting Chua
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Shermyn X. M. Neo
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Shermyn X. M. Neo
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Zheyu Xu
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Zheyu Xu
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Kay-Yaw Tay
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Kay-Yaw Tay
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Kay-Yaw Tay
- Duke-NUS Graduate Medical School, Singapore, Singapore
- Wing-Lok Au
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Wing-Lok Au
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Wing-Lok Au
- Duke-NUS Graduate Medical School, Singapore, Singapore
- Eng-King Tan
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Eng-King Tan
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Eng-King Tan
- Duke-NUS Graduate Medical School, Singapore, Singapore
- Louis C. S. Tan
- Department of Neurology, National Neuroscience Institute, Singapore, Singapore
- Louis C. S. Tan
- Parkinson's Disease and Movement Disorders Centre (Parkinson Foundation's International Center of Excellence), National Neuroscience Institute, Singapore, Singapore
- Louis C. S. Tan
- Duke-NUS Graduate Medical School, Singapore, Singapore
- DOI
- https://doi.org/10.3389/fneur.2021.704906
- Journal volume & issue
-
Vol. 12
Abstract
Background: Various classifications have been proposed to subtype Parkinson's disease (PD) based on their motor phenotypes. However, the stability of these subtypes has not been properly evaluated.Objective: The goal of this study was to understand the distribution of PD motor subtypes, their stability over time, and baseline factors that predicted subtype stability.Methods: Participants (n = 170) from two prospective cohorts were included: the Early PD Longitudinal Singapore (PALS) study and the National Neuroscience Institute Movement Disorders Database. Early PD patients were classified into tremor-dominant (TD), postural instability and gait difficulty (PIGD), and indeterminate subtypes according to the Movement Disorder Society's Unified PD Rating Scale (MDS-UPDRS) criteria and clinically evaluated for three consecutive years.Results: At baseline, 60.6% patients were TD, 12.4% patients were indeterminate, and 27.1% patients were PIGD subtypes (p < 0.05). After 3 years, only 62% of patients in TD and 50% of patients in PIGD subtypes remained stable. The mean levodopa equivalent daily dose (LEDD) was higher in the PIGD subtype (276.92 ± 232.91 mg; p = 0.01). Lower LEDD [p < 0.05, odds ratio (OR) 0.99, 95% confidence interval (CI): 0.98–0.99] and higher TD/PIGD ratios (p < 0.05, OR 1.77, 95% CI: 1.29–2.43) were independent predictors of stability of TD subtype with an area under the curve (AUC) of 0.787 (95%CI: 0.669–0.876), sensitivity = 57.8%, and specificity = 89.7%.Conclusion: Only 50–62% of PD motor subtypes as defined by MDS-UPDRS remained stable over 3 years. TD/PIGD ratio and baseline LEDD were independent predictors for TD subtype stability over 3 years.
Keywords
- subtype
- parkinson's disease
- tremor dominant (TD)
- postural instability and gait difficulties
- indeterminate
- over time